Andrew T. Pavia
No Rating Available
(Learn About Our Rating System)

Andrew T. Pavia, MD

Languages spoken: English, French, Italian

Clinical Locations

Primary Location

Eccles Primary Children's Outpatient Services

81 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-213-3599
Get Directions

  • Dr. Pavia received his bachelor's degree and medical degree at Brown University. He trained in internal medicine and pediatrics at Dartmouth and the University of Utah. At the Centers for Disease Control and Prevention, Dr. Pavia trained in Public Health Epidemiology as an Epidemic Intelligence Service (EIS) officer and a Preventive Medicine Resident. Additionally, Dr. Pavia completed a fellowship in pediatric and adult infectious diseases at the University of Utah. He joined the faculty at the University of Utah in 1991. In 2003 Dr. Pavia became the George and Esther Gross Presidential Professor and Chief of the Division of Pediatric Infectious Diseases, where he mentors a dynamic and productive team of faculty and fellows. He also serves as Director of Hospital Epidemiology at Primary Children's Hospital and Associate Director of Antimicrobial Stewardship. Dr. Pavia is a member of the Society for Pediatric Research. He is a Fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Dr. Pavia is a member of the National Academy of Science Engineering and Medicine Forum on Preparedness. He was recently Vice Chair and Chair of the Program Committee for IDWeek and served two terms on the CDC Board of Scientific Counselors. He has served as a member of the Board of Directors the Infectious Disease Society of America (IDSA) and past chair of the Pandemic Influenza Task Force and past Chair of the National and Global Public Policy Committee. Dr. Pavia served as a member of the National Vaccine Advisory Committee and chaired the Vaccine Safety Working Group, was an inaugural member of the National Biodefense Science Board (NBSB) and chaired the Influenza Working Group, and co-chaired the Personal Preparedness Working Group of the NBSB from 2008-2010. Dr. Pavia has served on several Institute of Medicine Committees including “Antivirals for Pandemic Influenza: Guidance on Developing and Distribution and Dispensing System,” and “Prepositioned Medical Countermeasure for the Public,” and is a frequent consultant for CDC. He is an associate Editor of the Sanford Guide to Antimicrobial Therapy and is on the editorial board the Journal of the Pediatric Infectious Disease Society and a reviewer for numerous journals. He has published more than 250 peer-reviewed scientific articles, textbook chapters, reviews and scientific abstracts. His research interests include the epidemiology of influenza and other emerging respiratory infections, pneumonia, vaccine preventable diseases, emerging infections, and HIV/ AIDS, with a particular interest in infections of pregnant women and their children. He has been the principal investigator or co-investigator on grants from the National Institutes of Health, the Bill and Melinda Gates Foundation, and the Centers for Disease Control and Prevention.

    Dr. Pavia received his undergraduate and medical degrees from Brown University. He completed his residency at Dartmouth Hitchcock Medical Center and served as Chief Resident. He then served as an officer in the Epidemic Intelligence Service at the Centers for Disease Control and Prevention and completed a residency in Preventive Medicine. He completed fellowship training in pediatric and adult infectious diseases at the University of Utah. Dr. Pavia is currently the George and Esther Gross Presidential Professor at the University of Utah and is Chief of the Division of Pediatric Infectious Diseases. His academic interests include the epidemiology, diagnosis and management of emerging infectious diseases including influenza, respiratory infections and diarrheal diseases. He is also keenly interested in HIV/AIDS and has been involved in HIV clinical care and research since the 1980’s.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)

  • Dr. Pavia received his bachelor's degree and medical degree at Brown University. He trained in internal medicine and pediatrics at Dartmouth and the University of Utah. At the Centers for Disease Control and Prevention, Dr. Pavia trained in Public Health Epidemiology as an Epidemic Intelligence Service (EIS) officer and a Preventive Medicine Resident. Additionally, Dr. Pavia completed a fellowship in pediatric and adult infectious diseases at the University of Utah. He joined the faculty at the University of Utah in 1991. In 2003 Dr. Pavia became the George and Esther Gross Presidential Professor and Chief of the Division of Pediatric Infectious Diseases, where he mentors a dynamic and productive team of faculty and fellows. He also serves as Director of Hospital Epidemiology at Primary Children's Hospital and Associate Director of Antimicrobial Stewardship. Dr. Pavia is a member of the Society for Pediatric Research. He is a Fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Dr. Pavia is a member of the National Academy of Science Engineering and Medicine Forum on Preparedness. He was recently Vice Chair and Chair of the Program Committee for IDWeek and served two terms on the CDC Board of Scientific Counselors. He has served as a member of the Board of Directors the Infectious Disease Society of America (IDSA) and past chair of the Pandemic Influenza Task Force and past Chair of the National and Global Public Policy Committee. Dr. Pavia served as a member of the National Vaccine Advisory Committee and chaired the Vaccine Safety Working Group, was an inaugural member of the National Biodefense Science Board (NBSB) and chaired the Influenza Working Group, and co-chaired the Personal Preparedness Working Group of the NBSB from 2008-2010. Dr. Pavia has served on several Institute of Medicine Committees including “Antivirals for Pandemic Influenza: Guidance on Developing and Distribution and Dispensing System,” and “Prepositioned Medical Countermeasure for the Public,” and is a frequent consultant for CDC. He is an associate Editor of the Sanford Guide to Antimicrobial Therapy and is on the editorial board the Journal of the Pediatric Infectious Disease Society and a reviewer for numerous journals. He has published more than 250 peer-reviewed scientific articles, textbook chapters, reviews and scientific abstracts. His research interests include the epidemiology of influenza and other emerging respiratory infections, pneumonia, vaccine preventable diseases, emerging infections, and HIV/ AIDS, with a particular interest in infections of pregnant women and their children. He has been the principal investigator or co-investigator on grants from the National Institutes of Health, the Bill and Melinda Gates Foundation, and the Centers for Disease Control and Prevention.

    Dr. Pavia received his undergraduate and medical degrees from Brown University. He completed his residency at Dartmouth Hitchcock Medical Center and served as Chief Resident. He then served as an officer in the Epidemic Intelligence Service at the Centers for Disease Control and Prevention and completed a residency in Preventive Medicine. He completed fellowship training in pediatric and adult infectious diseases at the University of Utah. Dr. Pavia is currently the George and Esther Gross Presidential Professor at the University of Utah and is Chief of the Division of Pediatric Infectious Diseases. His academic interests include the epidemiology, diagnosis and management of emerging infectious diseases including influenza, respiratory infections and diarrheal diseases. He is also keenly interested in HIV/AIDS and has been involved in HIV clinical care and research since the 1980’s.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Professor
    Internal Medicine -Adjunct Professor
    Academic Divisions Infectious Diseases
    Infectious Diseases
    Board Certification
    American Board of Internal Medicine (Internal Medicine)

    Education history

    Undergraduate English Literature and Biology - Brown University A.B.
    Professional Medical Medicine - Brown University M.D.
    Internship Internal Medicine - Dartmouth-Hitcock Medical Center Intern
    Residency Internal Medicine - Dartmouth-Hitcock Medical Center Resident
    Chief Resident Internal Medicine - Dartmouth-Hitcock Medical Center Chief Resident
    Post Graduate Training Epidemiology - New England Epidemiology Institute Summer Program
    Other Training Centers for Disease Control EIS
    Residency Preventive Medicine - Centers for Disease Control and Prevention Resident
    Fellowship Adult/Pediatric Infectious Disease - University of Utah School of Medicine Fellow

    Selected Publications

    Journal Article

    1. Pavia AT, Nielsen L, Armington L, Thurman DJ, Tierney E, Nichols CR (1990). A community-wide outbreak of hepatitis A in a religious community: impact of mass administration of immune globulin. Am J Epidemiol, 131(6), 1085-93. (Read full publication)
    2. Chute CG, Baron JA, Plymate SR, Kiel DP, Pavia AT, Lozner EC, O'Keefe T, MacDonald GJ (1987). Sex hormones and coronary artery disease. Am J Med, 83(5), 853-9. (Read full publication)
    3. Riley DK, Pavia AT, Beatty PG, Petersen FB, Spruance JL, Stokes R, Evans TG (1994). The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. Am J Med, 97(6), 509-14. (Read full publication)
    4. Pavia AT, Benyo M, Niler L, Risk I (1993). Partner notification for control of HIV: results after 2 years of a statewide program in Utah. Am J Public Health, 83(10), 1418-24. (Read full publication)
    5. Christenson JC, Byington C, Korgenski EK, Adderson EE, Bruggers C, Adams RH, Jenkins E, Hohmann S, Carroll K, Daly JA, Pavia AT (1999). Bacillus cereus infections among oncology patients at a children's hospital. Am J Infect Control, 27(6), 543-6. (Read full publication)
    6. Blaschke AJ, Korgenski EK, Daly JA, LaFleur B, Pavia AT, Byington CL (2009). Extended-spectrum beta-lactamase-producing pathogens in a children's hospital: a 5-year experience. Am J Infect Control, 37(6), 435-41. (Read full publication)
    7. Pavia AT, Bryan JA, Maher KL, Hester TR Jr, Farmer JJ 3rd (1989). Vibrio carchariae infection after a shark bite. Ann Intern Med, 111(1), 85-6. (Read full publication)
    8. Spruance SL, Pavia AT, Peterson D, Berry A, Pollard R, Patterson TF, Frank I, Remick SC, Thompson M, MacArthur RD, Morey GE, Ramirez-Ronda CH, Bernstein BM, Sweet DE, Crane L, Peterson EA, Pachucki CT, Green SL, Brand J, Rios A, Dunkle LM, Cross A, Brown MJ, Ingraham P, Gugliotti R, Schindzielorz AH, Smaldone L (1994). Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group. Ann Intern Med, 120(5), 360-8. (Read full publication)
    9. Spruance SL, Pavia AT, Mellors JW, Murphy R, Gathe J Jr, Stool E, Jemsek JG, Dellamonica P, Cross A, Dunkle L (1997). Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group. Ann Intern Med, 126(5), 355-63. (Read full publication)
    10. Pavia AT (2012). Laboratory creation of a highly transmissible H5N1 influenza virus: balancing substantial risks and real benefits. Ann Intern Med, 156(6), 463-5. (Read full publication)
    11. Pavia AT (2013). Influenza A(H7N9): from anxiety to preparedness. Ann Intern Med, 159(3), 219-20. (Read full publication)
    12. Kuriakose S, Singh K, Pau AK, Daar E, Gandhi R, Tebas P, Evans L, Gulick RM, Lane HC, Masur H, NIH COVID-19 Treatment Guidelines Panel., Aberg JA, Adimora AA, Baker J, Kreuziger LB, Bedimo R, Belperio PS, Cantrill SV, Coopersmith CM, Davis SL, Dzierba AL, Gallagher JJ, Glidden DV, Grund B, Hardy EJ, Hinkson C, Hughes BL, Johnson S, Keller MJ, Kim AY, Lennox JL, Levy MM, Li JZ, Martin GS, Naggie S, Pavia AT, Seam N, Simpson SQ, Swindells S, Tien P, Waghmare AA, Wilson KC, Yazdany J, Zachariah P, Campbell DM, Harrison C, Burgess T, Francis J, Sheikh V, Uyeki TM, Walker R, Brooks JT, Ortiz LB, Davey RT Jr, Doepel LK, Eisinger RW, Han A, Higgs ES, Nason MC, Crew P, Lerner AM, Lund C, Worthington (2021). Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19. Annals of internal medicine, 174(8), 1151-1158. (Read full publication)
    13. Meadows KP, Tyring SK, Pavia AT, Rallis T (1997). Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir. Archives of dermatology, 133(8), 987-90. (Read full publication)
    14. Lowry PW, Pavia AT, McFarland LM, Peltier BH, Barrett TJ, Bradford HB, Quan JM, Lynch J, Mathison JB, Gunn R (1989). Cholera in Louisiana. Widening spectrum of seafood vehicles. Archives of internal medicine, 149(9), 2079-84. (Read full publication)
    15. Kriesel JD, Adderson EE, Gooch WM 3rd, Pavia A (1994). Invasive sinonasal disease due to Scopulariopsis candida: case report and review of scopulariopsosis. Clinical infectious diseases, 19(2), 317-9. (Read full publication)
    16. Chapman LE, Ellis BA, Koster FT, Sotir M, Ksiazek TG, Mertz GJ, Rollin PE, Baum KF, Pavia AT, Christenson JC, Rubin PJ, Jolson HM, Behrman RE, Khan AS, Bell LJ, Simpson GL, Hawk J, Holman RC, Peters CJ, Ribavirin Study Group (2002). Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome. Clinical infectious diseases, 34(3), 293-304. (Read full publication)
    17. Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO, Kaplan S, Carroll KC, Daly JA, Christenson JC, Samore M (2002). An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clinical infectious diseases, 34(4), 434-40. (Read full publication)
    18. Mertz GJ, Miedzinski L, Goade D, Pavia AT, Hjelle B, Hansbarger CO, Levy H, Koster FT, Baum K, Lindemulder A, Wang W, Riser L, Fernandez H, Whitley RJ, Collaborative Antiviral Study Group (2004). Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clinical infectious diseases, 39(9), 1307-13. (Read full publication)
    19. Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, Glover D, Jensen J, Mason EO, Shutt CK, Pavia A (2005). Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clinical infectious diseases, 41(1), 21-9. (Read full publication)
    20. Blaschke AJ, Bender J, Byington CL, Korgenski K, Daly J, Petti CA, Pavia AT, Ampofo (2007). Gordonia species: emerging pathogens in pediatric patients that are identified by 16S ribosomal RNA gene sequencing. Clinical infectious diseases, 45(4), 483-6. (Read full publication)
    21. Bender JM, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO, Byington C (2008). Pneumococcal necrotizing pneumonia in Utah: does serotype matter?. Clinical infectious diseases, 46(9), 1346-52. (Read full publication)
    22. Byington CL, Bender JM, Ampofo K, Pavia AT, Korgenski K, Daly J, Christenson JC, Adderson (2008). Tularemia with vesicular skin lesions may be mistaken for infection with herpes viruses. Clinical infectious diseases, 47(1), e4-6. (Read full publication)
    23. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, McGeer AJ, Neuzil KM, Pavia AT, Tapper ML, Uyeki TM, Zimmerman RK, Expert Panel of the Infectious Diseases Society of America (2009). Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clinical infectious diseases, 48(8), 1003-32. (Read full publication)
    24. Bender JM, Cox CM, Mottice S, She RC, Korgenski K, Daly JA, Pavia A (2010). Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine. Clinical infectious diseases, 50(7), e41-6. (Read full publication)
    25. Pavia A (2011). Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clinical infectious diseases, 52 Suppl 4, S284-9. (Read full publication)
    26. Stockmann C, Ampofo K, Hersh AL, Blaschke AJ, Kendall BA, Korgenski K, Daly J, Hill HR, Byington CL, Pavia A (2012). Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010. Clinical infectious diseases, 55(4), 479-87. (Read full publication)
    27. Byington CL, Ampofo K, Stockmann C, Adler FR, Herbener A, Miller T, Sheng X, Blaschke AJ, Crisp R, Pavia A (2015). Community Surveillance of Respiratory Viruses Among Families in the Utah Better Identification of Germs-Longitudinal Viral Epidemiology (BIG-LoVE) Study. Clinical infectious diseases, 61(8), 1217-24. (Read full publication)
    28. Stockmann C, Ampofo K, Pavia AT, Blaschke AJ, Mason EO, Presson AP, Forney LJ, Byington C (2016). Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics. Clinical infectious diseases, 63(5), 619-626. (Read full publication)
    29. Stenehjem E, Hersh AL, Sheng X, Jones P, Buckel WR, Lloyd JF, Howe S, Evans RS, Greene T, Pavia A (2016). Antibiotic Use in Small Community Hospitals. Clinical infectious diseases, 63(10), 1273-1280. (Read full publication)
    30. Kabbani S, Hersh AL, Shapiro DJ, Fleming-Dutra KE, Pavia AT, Hicks L (2018). Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits. Clinical infectious diseases, 67(1), 134-136. (Read full publication)
    31. Kutty PK, Jain S, Taylor TH, Bramley AM, Diaz MH, Ampofo K, Arnold SR, Williams DJ, Edwards KM, McCullers JA, Pavia AT, Winchell JM, Schrag SJ, Hicks L (2019). Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia. Clinical infectious diseases, 68(1), 5-12. (Read full publication)
    32. Stenehjem E, Hersh AL, Buckel WR, Jones P, Sheng X, Evans RS, Burke JP, Lopansri BK, Srivastava R, Greene T, Pavia A (2018). Impact of Implementing Antibiotic Stewardship Programs in 15 Small Hospitals: A Cluster-Randomized Intervention. Clinical infectious diseases, 67(4), 525-532. (Read full publication)
    33. Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia A (2019). Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clinical infectious diseases, 68(6), 895-902. (Read full publication)
    34. Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia A (2019). Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clinical infectious diseases, 68(6), e1-e47. (Read full publication)
    35. Howard LM, Edwards KM, Zhu Y, Grijalva CG, Self WH, Jain S, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Williams D (2021). Clinical Features of Human Metapneumovirus-Associated Community-acquired Pneumonia Hospitalizations. Clinical infectious diseases, 72(1), 108-117. (Read full publication)
    36. Howard LM, Edwards KM, Zhu Y, Williams DJ, Self WH, Jain S, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Grijalva C (2020). Parainfluenza Virus Types 1-3 Infections Among Children and Adults Hospitalized with Community-Acquired Pneumonia. Clinical infectious diseases, 73, e4433-e4443. (Read full publication)
    37. van Leeuwen R, Katlama C, Murphy RL, Squires K, Gatell J, Horban A, Clotet B, Staszewski S, van Eeden A, Clumeck N, Moroni M, Pavia AT, Schmidt RE, Gonzalez-Lahoz J, Montaner J, Antunes F, Gulick R, Bánhegyi D, van der Valk M, Reiss P, van Weert L, van Leth F, Johnson VA, Sommadossi JP, Lange J (2003). A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients. AIDS (London, England), 17(7), 987-99. (Read full publication)
    38. National Vaccine Advisory Committee., Stokley S, Freed G, Curtis R, Gordon L, Humiston S, Parnell T, Pavia A, Young A, Johnson D, Kennedy A, Hopfensperger D, Markowitz L, Fergie J, Koslap-Petraco MB, McCauley (2009). Adolescent vaccination: recommendations from the National Vaccine Advisory Committee. American journal of preventive medicine, 36(3), 278-9.e6. (Read full publication)
    39. Christenson JC, Pavia AT, Seskin K, Brockmeyer D, Korgenski EK, Jenkins E, Pierce J, Daly J (1997). Meningitis due to Ochrobactrum anthropi: an emerging nosocomial pathogen. A report of 3 cases. Pediatric neurosurgery, 27(4), 218-21. (Read full publication)
    40. Struwe M, Kaempfer SH, Geiger CJ, Pavia AT, Plasse TF, Shepard KV, Ries K, Evans T (1993). Effect of dronabinol on nutritional status in HIV infection. The Annals of pharmacotherapy, 27(7-8), 827-31. (Read full publication)
    41. Rocha BH, Christenson JC, Pavia A, Evans RS, Gardner R (1994). Computerized detection of nosocomial infections in newborns. Proceedings. Symposium on Computer Applications in Medical Care, 684-8. (Read full publication)
    42. Barrett TJ, Green JH, Griffin PM, Pavia AT, Ostroff SM, Wachsmuth I (1991). Enzyme-linked immunosorbent assays for detecting antibodies to Shiga-like toxin I, Sigan-like toxin II, and Escherichia coli O157:H7 lipopolysaccharide in human serum. Current microbiology, 23, 189-195.
    43. Riley DK, Pavia AT, Beatty PG, Denton D, Carroll K (1995). Surveillance cultures in bone marrow transplant recipients: worthwhile or wasteful?. Bone marrow transplantation, 15(3), 469-73. (Read full publication)
    44. Siegler RL, Pavia AT, Cook J (1997). Hemolytic-uremic syndrome in adolescents. Archives of pediatrics & adolescent medicine, 151(2), 165-9. (Read full publication)
    45. Byington CL, Castillo H, Gerber K, Daly JA, Brimley LA, Adams S, Christenson JC, Pavia A (2002). The effect of rapid respiratory viral diagnostic testing on antibiotic use in a children's hospital. Archives of pediatrics & adolescent medicine, 156(12), 1230-4. (Read full publication)
    46. Haddad MB, Porucznik CA, Joyce KE, De AK, Pavia AT, Rolfs RT, Byington C (2008). Risk factors for pediatric invasive pneumococcal disease in the Intermountain West, 1996-2002. Annals of epidemiology, 18(2), 139-46. (Read full publication)
    47. Hardin DS, Rice J, Doyle ME, Pavia (2005). Growth hormone improves protein catabolism and growth in prepubertal children with HIV infection. Clinical endocrinology, 63(3), 259-62. (Read full publication)
    48. Siegler RL, Sherbotie JR, Denkers ND, Pavia A (2003). Clustering of post-diarrheal (Shiga toxin-mediated) hemolytic uremic syndrome in families. Clinical nephrology, 60(2), 74-9. (Read full publication)
    49. Siegler RL, Pavia AT, Sherbotie J (2002). Recurrent hemolytic uremic syndrome. Clinical pediatrics, 41(9), 705-9. (Read full publication)
    50. Blaschke AJ, Heyrend C, Byington CL, Fisher MA, Barker E, Garrone NF, Thatcher SA, Pavia AT, Barney T, Alger GD, Daly JA, Ririe KM, Ota I, Poritz M (2012). Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagnostic microbiology and infectious disease, 74(4), 349-55. (Read full publication)
    51. Adderson EE, Pavia AT, Christenson JC, Davis R, Leonard RB, Carroll K (2000). A community pseudo-outbreak of invasive Staphylococcus aureus infection. Diagnostic microbiology and infectious disease, 37, 219-21.
    52. Adderson E, Pavia A, Christenson J, Davis R, Leonard R, Carroll (2000). A community pseudo-outbreak of invasive Staphylococcus aureus infection. Diagnostic microbiology and infectious disease, 37(3), 219-21. (Read full publication)
    53. Shapiro DJ, Hicks LA, Pavia AT, Hersh A (2014). Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. The Journal of antimicrobial chemotherapy, 69(1), 234-40. (Read full publication)
    54. Byington CL, Hulten KG, Ampofo K, Sheng X, Pavia AT, Blaschke AJ, Pettigrew M, Korgenski K, Daly J, Mason E (2010). Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. Journal of clinical microbiology, 48(2), 520-5. (Read full publication)
    55. Zhang Y, Sakthivel SK, Bramley A, Jain S, Haynes A, Chappell JD, Hymas W, Lenny N, Patel A, Qi C, Ampofo K, Arnold SR, Self WH, Williams DJ, Hillyard D, Anderson EJ, Grijalva CG, Zhu Y, Wunderink RG, Edwards KM, Pavia AT, McCullers JA, Erdman D (2016). Serology Enhances Molecular Diagnosis of Respiratory Virus Infections Other than Influenza in Children and Adults Hospitalized with Community-Acquired Pneumonia. Journal of clinical microbiology, 55(1), 79-89. (Read full publication)
    56. Bonkowsky JL, Christenson JC, Nixon GW, Pavia A (2002). Cerebral aneurysms in a child with acquired immune deficiency syndrome during rapid immune reconstitution. Journal of child neurology, 17(6), 457-60. (Read full publication)
    57. Knackstedt ED, Stockmann C, Davis CR, Thorell EA, Pavia AT, Hersh A (2015). Outpatient parenteral antimicrobial therapy in pediatrics: an opportunity to expand antimicrobial stewardship. Infection control and hospital epidemiology, 36(2), 222-4. (Read full publication)
    58. Bender JM, Virgallito M, Newland JG, Sammons JS, Thorell EA, Coffin SE, Pavia AT, Sandora TJ, Hersh A (2015). Infection prevention and control practices in children's hospitals. Infection control and hospital epidemiology, 36(5), 597-600. (Read full publication)
    59. Spivak ES, Kendall B, Orlando P, Perez C, De Amorim M, Samore M, Pavia AT, Hersh A (2015). Evaluation of Outpatient Parenteral Antimicrobial Therapy at a Veterans Affairs Hospital. Infection control and hospital epidemiology, 36(9), 1103-5. (Read full publication)
    60. Pavia A (2013). What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?. Infectious disease clinics of North America, 27(1), 157-75. (Read full publication)
    61. Pavia AT, Shipman LD, Wells JG, Puhr ND, Smith JD, McKinley TW, Tauxe R (1990). Epidemiologic evidence that prior antimicrobial exposure decreases resistance to infection by antimicrobial-sensitive Salmonella. The Journal of infectious diseases, 161(2), 255-60. (Read full publication)
    62. Chang HJ, Christenson JC, Pavia AT, Bobrin BD, Bland LA, Carson LA, Arduino MJ, Verma P, Aguero SM, Carroll K, Jenkins E, Daly JA, Woods ML, Jarvis W (1996). Ochrobactrum anthropi meningitis in pediatric pericardial allograft transplant recipients. The Journal of infectious diseases, 173(3), 656-60. (Read full publication)
    63. Litwin CM, Leonard RB, Carroll KC, Drummond WK, Pavia A (1997). Characterization of endemic strains of Shigella sonnei by use of plasmid DNA analysis and pulsed-field gel electrophoresis to detect patterns of transmission. The Journal of infectious diseases, 175(4), 864-70. (Read full publication)
    64. Deeks SG, Collier A, Lalezari J, Pavia A, Rodrigue D, Drew WL, Toole J, Jaffe HS, Mulato AS, Lamy PD, Li W, Cherrington JM, Hellmann N, Kahn (1997). The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial. The Journal of infectious diseases, 176(6), 1517-23. (Read full publication)
    65. Ioannidis JP, Collier AC, Cooper DA, Corey L, Fiddian AP, Gazzard BG, Griffiths PD, Contopoulos-Ioannidis DG, Lau J, Pavia AT, Saag MS, Spruance SL, Youle M (1998). Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. The Journal of infectious diseases, 178(2), 349-59. (Read full publication)
    66. Hayden FG, Pavia A (2006). Antiviral management of seasonal and pandemic influenza. The Journal of infectious diseases, 194 Suppl 2, S119-26. (Read full publication)
    67. Whitley RJ, Bartlett J, Hayden FG, Pavia AT, Tapper M, Monto A (2006). Seasonal and pandemic influenza: recommendations for preparedness in the United States. The Journal of infectious diseases, 194 Suppl 2, S155-61. (Read full publication)
    68. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright L (2008). Evidence for a heritable predisposition to death due to influenza. The Journal of infectious diseases, 197(1), 18-24. (Read full publication)
    69. Ison MG, de Jong MD, Gilligan KJ, Higgs ES, Pavia AT, Pierson J, Hayden F (2010). End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease. The Journal of infectious diseases, 201(11), 1654-62. (Read full publication)
    70. Self WH, Williams DJ, Zhu Y, Ampofo K, Pavia AT, Chappell JD, Hymas WC, Stockmann C, Bramley AM, Schneider E, Erdman D, Finelli L, Jain S, Edwards KM, Grijalva C (2016). Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia. The Journal of infectious diseases, 213(4), 584-91. (Read full publication)
    71. Schlaberg R, Queen K, Simmon K, Tardif K, Stockmann C, Flygare S, Kennedy B, Voelkerding K, Bramley A, Zhang J, Eilbeck K, Yandell M, Jain S, Pavia AT, Tong S, Ampofo (2017). Viral Pathogen Detection by Metagenomics and Pan-Viral Group Polymerase Chain Reaction in Children With Pneumonia Lacking Identifiable Etiology. The Journal of infectious diseases, 215(9), 1407-1415. (Read full publication)
    72. Bramley AM, Reed C, Finelli L, Self WH, Ampofo K, Arnold SR, Williams DJ, Grijalva CG, Anderson EJ, Stockmann C, Trabue C, Fakhran S, Balk R, McCullers JA, Pavia AT, Edwards KM, Wunderink RG, Jain S, Centers for Disease Control and Prevention Etiology of Pneumonia in the Community (EPIC) Study Team (2017). Relationship Between Body Mass Index and Outcomes Among Hospitalized Patients With Community-Acquired Pneumonia. The Journal of infectious diseases, 215(12), 1873-1882. (Read full publication)
    73. Schlaberg R, Ampofo K, Tardif KD, Stockmann C, Simmon KE, Hymas W, Flygare S, Kennedy B, Blaschke A, Eilbeck K, Yandell M, McCullers JA, Williams DJ, Edwards K, Arnold SR, Bramley A, Jain S, Pavia A (2017). Human Bocavirus Capsid Messenger RNA Detection in Children With Pneumonia. The Journal of infectious diseases, 216(6), 688-696. (Read full publication)
    74. Lu X, Schneider E, Jain S, Bramley AM, Hymas W, Stockmann C, Ampofo K, Arnold SR, Williams DJ, Self WH, Patel A, Chappell JD, Grijalva CG, Anderson EJ, Wunderink RG, McCullers JA, Edwards KM, Pavia AT, Erdman D (2017). Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia. The Journal of infectious diseases, 216(9), 1104-1111. (Read full publication)
    75. Nolan VG, Arnold SR, Bramley AM, Ampofo K, Williams DJ, Grijalva CG, Self WH, Anderson EJ, Wunderink RG, Edwards KM, Pavia AT, Jain S, McCullers J (2018). Etiology and Impact of Coinfections in Children Hospitalized With Community-Acquired Pneumonia. The Journal of infectious diseases, 218(2), 179-188. (Read full publication)
    76. Pavia AT, Nichols CR, Green DP, Tauxe RV, Mottice S, Greene KD, Wells JG, Siegler RL, Brewer ED, Hannon (1990). Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. The Journal of pediatrics, 116(4), 544-51. (Read full publication)
    77. Siegler RL, Pavia AT, Hansen FL, Christofferson RD, Cook J (1996). Atypical hemolytic-uremic syndrome: a comparison with postdiarrheal disease. The Journal of pediatrics, 128(4), 505-11. (Read full publication)
    78. Shakib JH, Korgenski K, Sheng X, Varner MW, Pavia AT, Byington C (2013). Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes. The Journal of pediatrics, 163(5), 1422-6.e1-4. (Read full publication)
    79. Ahn A, Edwards KM, Grijalva CG, Self WH, Zhu Y, Chappell JD, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Bramley AM, Jain S, Williams D (2015). Secondhand Smoke Exposure and Illness Severity among Children Hospitalized with Pneumonia. The Journal of pediatrics, 167(4), 869-874.e1. (Read full publication)
    80. Millman AJ, Finelli L, Bramley AM, Peacock G, Williams DJ, Arnold SR, Grijalva CG, Anderson EJ, McCullers JA, Ampofo K, Pavia AT, Edwards KM, Jain (2016). Community-Acquired Pneumonia Hospitalization among Children with Neurologic Disorders. The Journal of pediatrics, 173, 188-195.e4. (Read full publication)
    81. Adderson EE, Pappin A, Pavia A (1998). Spontaneous intestinal perforation in premature infants: a distinct clinical entity associated with systemic candidiasis. Journal of pediatric surgery, 33(10), 1463-7. (Read full publication)
    82. Woodruff BA, Pavia AT, Blake P (1991). A new look at typhoid vaccination. Information for the practicing physician. JAMA, 265(6), 756-9. (Read full publication)
    83. Davey RT Jr, Murphy RL, Graziano FM, Boswell SL, Pavia AT, Cancio M, Nadler JP, Chaitt DG, Dewar RL, Sahner DK, Duliege AM, Capra WB, Leong WP, Giedlin MA, Lane HC, Kahn J (2000). Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial. JAMA, 284(2), 183-9. (Read full publication)
    84. Grijalva CG, Zhu Y, Williams DJ, Self WH, Ampofo K, Pavia AT, Stockmann CR, McCullers J, Arnold SR, Wunderink RG, Anderson EJ, Lindstrom S, Fry AM, Foppa IM, Finelli L, Bramley AM, Jain S, Griffin MR, Edwards K (2015). Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination. JAMA, 314(14), 1488-97. (Read full publication)
    85. Pavia AT, Tauxe R (1987). Traveler's Diarrhea and the Soviet Union. JAMA, 258;1661.
    86. Ponz E, Piera C, Campistol JM, Lomeña F, Pavía A, Herranz R, Muñoz Gómez J, Setoain J, Revert (1990). [The gammagraphic diagnosis of dialysis-associated amyloidosis with beta 2-microglobulin-I-131. Preliminary results]. Medicina clinica, 95(14), 538-9. (Read full publication)
    87. Hughes MM, Carmack AE, McCaffrey K, Spencer M, Reed GM, Hill M, Dunn A, Risk I, Garg S, Reed C, Biggerstaff M, Mayer J, Gesteland P, Korgenski K, Dascomb K, Pavia A, Rolfes M (2019). Estimating the Incidence of Influenza at the State Level - Utah, 2016-17 and 2017-18 Influenza Seasons. MMWR. Morbidity and mortality weekly report, 68(50), 1158-1161. (Read full publication)
    88. Hargrett-Bean NT, Pavia AT, Tauxe R (1988). Salmonella isolates from humans in the United States, 1984-1986. MMWR. CDC surveillance summaries, 37(2), 25-31. (Read full publication)
    89. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, Stockmann C, Anderson EJ, Grijalva CG, Self WH, Zhu Y, Patel A, Hymas W, Chappell JD, Kaufman RA, Kan JH, Dansie D, Lenny N, Hillyard DR, Haynes LM, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, Wunderink RG, Edwards KM, Pavia AT, McCullers JA, Finelli L, CDC EPIC Study Team (2015). Community-acquired pneumonia requiring hospitalization among U.S. children. The New England journal of medicine, 372(9), 835-45. (Read full publication)
    90. Park AH, Muntz HR, Smith ME, Afify Z, Pysher T, Pavia (2005). Pediatric invasive fungal rhinosinusitis in immunocompromised children with cancer. Otolaryngology--head and neck surgery, 133(3), 411-6. (Read full publication)
    91. Leung DT, Chisti MJ, Pavia A (2016). Prevention and Control of Childhood Pneumonia and Diarrhea. Pediatric clinics of North America, 63(1), 67-79. (Read full publication)
    92. Pavia AT, Long EG, Ryder RW, Nsa W, Puhr ND, Wells JG, Martin P, Tauxe RV, Griffin P (1992). Diarrhea among African children born to human immunodeficiency virus 1-infected mothers: clinical, microbiologic and epidemiologic features. The Pediatric infectious disease journal, 11(12), 996-1003. (Read full publication)
    93. Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason E (2006). Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. The Pediatric infectious disease journal, 25(3), 250-4. (Read full publication)
    94. Keller M, Pavia AT, Byington C (2008). Possible intrafamilial transmission of Toxocara causing eosinophilic meningitis in an infant. The Pediatric infectious disease journal, 27(9), 849-50. (Read full publication)
    95. Bender JM, Rand TH, Ampofo K, Pavia AT, Schober M, Tebo A, Pasi B, Augustine NH, Pryor RJ, Wittwer CT, Hill H (2009). Family clusters of variant X-linked chronic granulomatous disease. The Pediatric infectious disease journal, 28(6), 529-33. (Read full publication)
    96. Powers AE, Bender JM, Kumánovics A, Ampofo K, Augustine N, Pavia AT, Hill H (2009). Coccidioides immitis meningitis in a patient with hyperimmunoglobulin E syndrome due to a novel mutation in signal transducer and activator of transcription. The Pediatric infectious disease journal, 28(7), 664-6. (Read full publication)
    97. Bender JM, Ampofo K, Gesteland P, Sheng X, Korgenski K, Raines B, Daly JA, Valentine K, Srivastava R, Pavia AT, Byington C (2010). Influenza virus infection in infants less than three months of age. The Pediatric infectious disease journal, 29(1), 6-9. (Read full publication)
    98. Ampofo K, Herbener A, Blaschke AJ, Heyrend C, Poritz M, Korgenski K, Rolfs R, Jain S, Carvalho Mda G, Pimenta FC, Daly J, Mason EO, Byington CL, Pavia A (2010). Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. The Pediatric infectious disease journal, 29(10), 905-9. (Read full publication)
    99. Bender JM, Ampofo K, Byington CL, Grinsell M, Korgenski K, Daly JA, Mason EO, Pavia A (2010). Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. The Pediatric infectious disease journal, 29(8), 712-6. (Read full publication)
    100. Blaschke AJ, Heyrend C, Byington CL, Obando I, Vazquez-Barba I, Doby EH, Korgenski EK, Sheng X, Poritz MA, Daly JA, Mason EO, Pavia AT, Ampofo (2011). Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. The Pediatric infectious disease journal, 30(4), 289-94. (Read full publication)
    101. Hersh AL, Herigon JC, Ampofo K, Pavia AT, Newland J (2011). Rapid increase in use of antiviral therapy for hospitalized children with influenza during the 2009 H1N1 epidemic. The Pediatric infectious disease journal, 30(10), 895-7. (Read full publication)
    102. Ampofo K, Pavia AT, Stockmann CR, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Byington C (2011). Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era. The Pediatric infectious disease journal, 30(12), 1100-3. (Read full publication)
    103. Ampofo K, Pavia AT, Stockmann C, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington C (2011). The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Children's Hospital through the PCV7 Era. The Pediatric infectious disease journal, (Read full publication)
    104. Olarte L, Ampofo K, Thorell EA, Sanderson S, Doby E, Pavia AT, Rosado H, Raoult D, Socolovschi C, Hersh A (2012). Bartonella vinsonii endocarditis in an adolescent with congenital heart disease. The Pediatric infectious disease journal, 31(5), 531-4. (Read full publication)
    105. Doby EH, Benjamin DK Jr, Blaschke AJ, Ward RM, Pavia AT, Martin PL, Driscoll TA, Cohen-Wolkowiez M, Moran (2012). Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children. The Pediatric infectious disease journal, 31(6), 632-5. (Read full publication)
    106. Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington C (2012). The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. The Pediatric infectious disease journal, 31(3), 228-34. (Read full publication)
    107. Stockmann C, Ampofo K, Hersh AL, Carleton ST, Korgenski K, Sheng X, Pavia AT, Byington C (2013). Seasonality of acute otitis media and the role of respiratory viral activity in children. The Pediatric infectious disease journal, 32(4), 314-9. (Read full publication)
    108. Stockmann C, Ampofo K, Pavia AT, Byington CL, Blaschke AJ, Sherwin CM, Spigarelli MG, Hersh A (2015). National trends in the incidence, outcomes and charges of pediatric osteoarticular infections, 1997-2012. The Pediatric infectious disease journal, 34(6), 672-4. (Read full publication)
    109. Nelson RE, Stockmann C, Hersh AL, Pavia AT, Korgenksi K, Daly JA, Couturier MR, Ampofo K, Thorell EA, Doby EH, Robison JA, Blaschke A (2015). Economic analysis of rapid and sensitive polymerase chain reaction testing in the emergency department for influenza infections in children. The Pediatric infectious disease journal, 34(6), 577-82. (Read full publication)
    110. Siegler RL, Pavia AT, Christofferson RD, Milligan M (1994). A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics, 94(1), 35-40. (Read full publication)
    111. Holmberg RE Jr, Pavia AT, Montgomery D, Clark JM, Eggert L (1993). Nosocomial Legionella pneumonia in the neonate. Pediatrics, 92(3), 450-3. (Read full publication)
    112. Staes CJ, Schlenker TL, Risk I, Cannon KG, Harris H, Pavia AT, Shapiro CN, Bell B (2000). Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics, 106(4), E54. (Read full publication)
    113. Adderson EE, Byington CL, Spencer L, Kimball A, Hindiyeh M, Carroll K, Mottice S, Korgenski EK, Christenson JC, Pavia A (2001). Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era?. Pediatrics, 108(1), E18. (Read full publication)
    114. Byington CL, Rittichier KK, Bassett KE, Castillo H, Glasgow TS, Daly J, Pavia A (2003). Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. Pediatrics, 111(5 Pt 1), 964-8. (Read full publication)
    115. Rocholl C, Gerber K, Daly J, Pavia AT, Byington C (2004). Adenoviral infections in children: the impact of rapid diagnosis. Pediatrics, 113(1 Pt 1), e51-6. (Read full publication)
    116. Haddad MB, Hill MB, Pavia AT, Green CE, Jumaan AO, De AK, Rolfs R (2005). Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 2002-2003. Pediatrics, 115(6), 1488-93. (Read full publication)
    117. Oakes RS, Siegler RL, McReynolds MA, Pysher T, Pavia A (2006). Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics, 117(5), 1656-62. (Read full publication)
    118. Ampofo K, Gesteland PH, Bender J, Mills M, Daly J, Samore M, Byington C, Pavia AT, Srivastava (2006). Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics, 118(6), 2409-17. (Read full publication)
    119. Ampofo K, Bender J, Sheng X, Korgenski K, Daly J, Pavia AT, Byington C (2008). Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics, 122(2), 229-37. (Read full publication)
    120. Hersh AL, Shapiro DJ, Pavia AT, Shah S (2011). Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics, 128(6), 1053-61. (Read full publication)
    121. Byington CL, Reynolds CC, Korgenski K, Sheng X, Valentine KJ, Nelson RE, Daly JA, Osguthorpe RJ, James B, Savitz L, Pavia AT, Clark E (2012). Costs and infant outcomes after implementation of a care process model for febrile infants. Pediatrics, 130(1), e16-24. (Read full publication)
    122. Olarte L, Ampofo K, Stockmann C, Mason EO, Daly JA, Pavia AT, Byington C (2013). Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7. Pediatrics, 132(1), e17-24. (Read full publication)
    123. Stockmann C, Ampofo K, Byington CL, Filloux F, Hersh AL, Blaschke AJ, Cowan P, Korgenski K, Mason EO, Pavia A (2013). Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics, 132(3), 421-8. (Read full publication)
    124. Bradley JS, Peacock G, Krug SE, Bower WA, Cohn AC, Meaney-Delman D, Pavia AT, AAP Committee on Infectious Diseases and Disaster Preparedness Advisory Council (2014). Pediatric anthrax clinical management: executive summary. Pediatrics, 133(5), 940-2. (Read full publication)
    125. Bradley JS, Peacock G, Krug SE, Bower WA, Cohn AC, Meaney-Delman D, Pavia AT, AAP Committee on Infectious Diseases and Disaster Preparedness Advisory Council (2014). Pediatric anthrax clinical management. Pediatrics, 133(5), e1411-36. (Read full publication)
    126. Williams DJ, Edwards KM, Self WH, Zhu Y, Ampofo K, Pavia AT, Hersh AL, Arnold SR, McCullers JA, Hicks LA, Bramley AM, Jain S, Grijalva C (2015). Antibiotic Choice for Children Hospitalized With Pneumonia and Adherence to National Guidelines. Pediatrics, 136(1), 44-52. (Read full publication)
    127. Shakib JH, Korgenski K, Presson AP, Sheng X, Varner MW, Pavia AT, Byington C (2016). Influenza in Infants Born to Women Vaccinated During Pregnancy. Pediatrics, 137(6), (Read full publication)
    128. Williams DJ, Zhu Y, Grijalva CG, Self WH, Harrell FE Jr, Reed C, Stockmann C, Arnold SR, Ampofo KK, Anderson EJ, Bramley AM, Wunderink RG, McCullers JA, Pavia AT, Jain S, Edwards K (2016). Predicting Severe Pneumonia Outcomes in Children. Pediatrics, 138(4), (Read full publication)
    129. Blaschke AJ, Korgenski EK, Wilkes J, Presson AP, Thorell EA, Pavia AT, Knackstedt ED, Reynolds C, Schunk JE, Daly JA, Byington C (2018). Rhinovirus in Febrile Infants and Risk of Bacterial Infection. Pediatrics, 141(2), (Read full publication)
    130. Coon ER, Srivastava R, Stoddard G, Wilkes J, Pavia AT, Shah S (2018). Shortened IV Antibiotic Course for Uncomplicated, Late-Onset Group B Streptococcal Bacteremia. Pediatrics, 142(5), (Read full publication)
    131. Fritz CQ, Edwards KM, Self WH, Grijalva CG, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Wunderink RG, Anderson EJ, Bramley AM, Jain S, Williams D (2019). Prevalence, Risk Factors, and Outcomes of Bacteremic Pneumonia in Children. Pediatrics, 144(1), (Read full publication)
    132. Bender JM, Ampofo K, Gesteland P, Stoddard GJ, Nelson D, Byington CL, Pavia AT, Srivastava (2009). Development and validation of a risk score for predicting hospitalization in children with influenza virus infection. Pediatric emergency care, 25(6), 369-75. (Read full publication)
    133. Kendall BA, Dascomb KK, Mehta RR, Mason EO, Ampofo K, Pombo DJ, Pavia AT, Byington C (2011). Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era. Vaccine, 29(49), 9123-6. (Read full publication)
    134. Kendall BA, Dascomb KK, Mehta RR, Stockmann C, Mason EO, Ampofo K, Pavia AT, Byington C (2016). Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children. Vaccine, 34(4), 474-478. (Read full publication)
    135. Rocha BHSC, Christenson JC, Pavia AT, Evans RS, Gardner R (1994). Computerized detection of nosocomial infections in newborns. Journal of the American Medical Informatics Association, S684-S688.
    136. Bender JM, Ampofo K, Sheng X, Pavia AT, Cannon-Albright L, Byington C (2009). Parapneumonic empyema deaths during past century, Utah. Emerging infectious diseases, 15(1), 44-8. (Read full publication)
    137. Rubach MP, Bender JM, Mottice S, Hanson K, Weng HY, Korgenski K, Daly JA, Pavia A (2011). Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. Emerging infectious diseases, 17(9), 1645-50. (Read full publication)
    138. Pavia A (1999). Advances in antimicrobial therapy. Seminars in pediatric neurology, 6(4), 288-98. (Read full publication)
    139. Stockmann C, Sherwin CM, Ampofo K, Hersh AL, Pavia AT, Byington CL, Ward RM, Spigarelli M (2013). Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov. International journal of antimicrobial agents, 42(2), 161-6. (Read full publication)
    140. Stockmann C, Rogatcheva M, Harrel B, Vaughn M, Crisp R, Poritz M, Thatcher S, Korgenski EK, Barney T, Daly J, Pavia A (2015). How well does physician selection of microbiologic tests identify Clostridium difficile and other pathogens in paediatric diarrhoea? Insights using multiplex PCR-based detection. Clinical microbiology and infection, 21(2), 179.e9-15. (Read full publication)
    141. Novotny T, Dingman JD, Pavia A (1987). Foodborne illness associated with a pig roast. Journal of food protection, 50, 945-47.
    142. Novotny T, Dingman JD, Pavia (1987). Foodborne Illness Associated with a Pig Roast. Journal of food protection, 50(11), 945-947. (Read full publication)
    143. Staes CJ, Wuthrich A, Gesteland P, Allison MA, Leecaster M, Shakib JH, Carter ME, Mallin BM, Mottice S, Rolfs R, Pavia AT, Wallace B, Gundlapalli AV, Samore M, Byington C (2011). Public health communication with frontline clinicians during the first wave of the 2009 influenza pandemic. Journal of public health management and practice, 17(1), 36-44. (Read full publication)
    144. Raboud JM, Montaner JS, Rae S, Kahn J, Hammer SM, Katzenstein DA, Pavia A, Dolin R, Hughes MD, Cross A, Beltangady M, Gatell J, Dunkle L, Smaldone (1997). Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals. Antiviral therapy, 2(4), 237-47. (Read full publication)
    145. Balch A, Wilkes J, Thorell E, Pavia A, Sherwin CMT, Enioutina E (2019). Changing trends in IVIG use in pediatric patients: A retrospective review of practices in a network of major USA pediatric hospitals. International immunopharmacology, 76, 105868. (Read full publication)
    146. Pavia (2019). One hundred years after the 1918 pandemic: new concepts for preparing for influenza pandemics. Current opinion in infectious diseases, 32(4), 365-371. (Read full publication)
    147. Delgado-Corcoran C, Van Dorn CS, Pribble C, Thorell EA, Pavia AT, Ward C, Smout R, Bratton SL, Burch P (2017). Reducing Pediatric Sternal Wound Infections: A Quality Improvement Project. Pediatric critical care medicine, 18(5), 461-468. (Read full publication)
    148. Schober ME, Pavia AT, Bohnsack J (2021). Neurologic Manifestations of COVID-19 in Children: Emerging Pathophysiologic Insights. Pediatric critical care medicine, 22(7), 655-661. (Read full publication)
    149. Gesteland PH, Samore MH, Pavia AT, Srivastava R, Korgenski K, Gerber K, Daly JA, Mundorff MB, Rolfs RT, James BC, Byington C (2007). Informing the front line about common respiratory viral epidemics. AMIA ... Annual Symposium proceedings. AMIA Symposium, 274-8. (Read full publication)
    150. Adler FR, Stockmann C, Ampofo K, Pavia AT, Byington C (2018). Transmission of rhinovirus in the Utah BIG-LoVE families: Consequences of age and household structure. PloS one, 13(7), e0199388. (Read full publication)
    151. Crandall H, Kapusta A, Killpack J, Heyrend C, Nilsson K, Dickey M, Daly JA, Ampofo K, Pavia AT, Mulvey MA, Yandell M, Hulten KG, Blaschke A (2020). Clinical and molecular epidemiology of invasive Staphylococcus aureus infection in Utah children; continued dominance of MSSA over MRSA. PloS one, 15(9), e0238991. (Read full publication)
    152. Frush JM, Zhu Y, Edwards KM, Grijalva CG, Thomsen IP, Self WH, Jain S, Anderson EJ, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Williams D (2018). Prevalence of Staphylococcus aureus and Use of Antistaphylococcal Therapy in Children Hospitalized with Pneumonia. Journal of hospital medicine, 13(12), 848-852. (Read full publication)
    153. Couturier BA, Bender JM, Schwarz MA, Pavia AT, Hanson KE, She R (2010). Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients. Influenza and other respiratory viruses, 4(4), 199-204. (Read full publication)
    154. Allison MA, Guest-Warnick G, Nelson D, Pavia AT, Srivastava R, Gesteland PH, Rolfs RT, Andersen S, Calame L, Young P, Byington C (2010). Feasibility of elementary school children's use of hand gel and facemasks during influenza season. Influenza and other respiratory viruses, 4(4), 223-9. (Read full publication)
    155. Brintz BJ, Howard JI, Haaland B, Platts-Mills JA, Greene T, Levine AC, Nelson EJ, Pavia AT, Kotloff KL, Leung D (2020). Clinical predictors for etiology of acute diarrhea in children in resource-limited settings. PLoS neglected tropical diseases, 14(10), e0008677. (Read full publication)
    156. Fischer PR, Christenson JC, Pavia AT, Orme G (1997). Post-operative Mycobacterium flavescens infection in a child. Infectious diseases in clinical practice (Baltimore, Md.), 6, 263-5.
    157. Brintz BJ, Haaland B, Howard J, Chao DL, Proctor JL, Khan AI, Ahmed SM, Keegan LT, Greene T, Keita AM, Kotloff KL, Platts-Mills JA, Nelson EJ, Levine AC, Pavia AT, Leung D (2021). A modular approach to integrating multiple data sources into real-time clinical prediction for pediatric diarrhea. eLife, 10, (Read full publication)
    158. Stockmann C, Ampofo K, Pavia AT, Byington CL, Sheng X, Greene TH, Korgenski EK, Hersh A (2015). Comparative Effectiveness of Oral Versus Outpatient Parenteral Antibiotic Therapy for Empyema. Hospital pediatrics, 5(12), 605-12. (Read full publication)
    159. Schwab EM, Wilkes J, Korgenski K, Hersh AL, Pavia AT, Stevens V (2016). Risk Factors for Recurrent Clostridium difficile Infection in Pediatric Inpatients. Hospital pediatrics, 6(6), 339-44. (Read full publication)
    160. Krah NM, Bardsley T, Nelson R, Esquibel L, Crosby M, Byington CL, Pavia AT, Hersh A (2019). Economic Burden of Home Antimicrobial Therapy: OPAT Versus Oral Therapy. Hospital pediatrics, 9(4), 234-240. (Read full publication)
    161. Sartori LF, Zhu Y, Grijalva CG, Ampofo K, Gesteland P, Johnson J, McHenry R, Arnold DH, Pavia AT, Edwards KM, Williams D (2021). Pneumonia Severity in Children: Utility of Procalcitonin in Risk Stratification. Hospital pediatrics, 11(3), 215-222. (Read full publication)
    162. Guerra AH, Stockmann C, Pavia AT, Hersh AL, Thorell EA, Weng HY, Korgenski K, Byington CL, Ampofo (2012). Laboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination. Journal of the Pediatric Infectious Diseases Society, 1(4), 268-77. (Read full publication)
    163. Blaschke AJ, Shapiro DJ, Pavia AT, Byington CL, Ampofo K, Stockmann C, Hersh A (2014). A National Study of the Impact of Rapid Influenza Testing on Clinical Care in the Emergency Department. Journal of the Pediatric Infectious Diseases Society, 3(2), 112-8. (Read full publication)
    164. Stockmann C, Pavia AT, Hersh AL, Spigarelli MG, Castle B, Korgenski K, Byington CL, Ampofo (2014). Age-Specific Patterns of Influenza Activity in Utah: Do Older School Age Children Drive the Epidemic?. Journal of the Pediatric Infectious Diseases Society, 3(2), 163-7. (Read full publication)
    165. Davis CR, Stockmann C, Pavia AT, Byington CL, Blaschke AJ, Hersh AL, Thorell EA, Korgenski K, Daly J, Ampofo (2016). Incidence, Morbidity, and Costs of Human Metapneumovirus Infection in Hospitalized Children. Journal of the Pediatric Infectious Diseases Society, 5(3), 303-11. (Read full publication)
    166. Hersh AL, Gerber JS, Hicks LA, Pavia A (2015). Lessons Learned in Antibiotic Stewardship: Fluoroquinolone Use in Pediatrics. Journal of the Pediatric Infectious Diseases Society, 4(1), 57-9. (Read full publication)
    167. Stockmann C, Pavia AT, Graham B, Vaughn M, Crisp R, Poritz MA, Thatcher S, Korgenski EK, Barney T, Daly J, Rogatcheva (2017). Detection of 23 Gastrointestinal Pathogens Among Children Who Present With Diarrhea. Journal of the Pediatric Infectious Diseases Society, 6(3), 231-238. (Read full publication)
    168. Stockmann C, Ampofo K, Killpack J, Williams DJ, Edwards KM, Grijalva CG, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Self WH, Bramley A, Jain S, Pavia AT, Blaschke A (2018). Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia. Journal of the Pediatric Infectious Diseases Society, 7(1), 46-53. (Read full publication)
    169. Hersh AL, Olson J, Stockmann C, Thorell EA, Knackstedt ED, Esquibel L, Sanderson S, Pavia A (2018). Impact of Antimicrobial Stewardship for Pediatric Outpatient Parenteral Antibiotic Therapy. Journal of the Pediatric Infectious Diseases Society, 7(2), e34-e36. (Read full publication)
    170. Krah NM, Olson J, Thorell EA, Esquibel L, Osguthorpe RJ, Pavia AT, Hersh A (2018). Outpatient Parenteral Antimicrobial Therapy in Young Infants. Journal of the Pediatric Infectious Diseases Society, 7(2), e40-e42. (Read full publication)
    171. Olson J, Mehra S, Hersh AL, Thorell EA, Stoddard GJ, Maese L, Barnette PE, Lemons RS, Pavia AT, Knackstedt E (2021). Oral Step-Down Therapy With Levofloxacin for Febrile Neutropenia in Children With Cancer. Journal of the Pediatric Infectious Diseases Society, 10(1), 27-33. (Read full publication)
    172. Crandall H, Christiansen J, Varghese AA, Russon A, Korgenski EK, Bengtson EK, Dickey M, Killpack J, Knackstedt ED, Daly JA, Ampofo K, Pavia AT, Blaschke A (2020). Clinical and Molecular Epidemiology of Invasive Haemophilus influenzae Serotype a Infections in Utah Children. Journal of the Pediatric Infectious Diseases Society, 9(6), 650-655. (Read full publication)
    173. Stockmann C, Byington CL, Pavia AT, Ampofo K, Wilkes J, Korgenski EK, Hersh A (2017). Limited and Variable Use of Antivirals for Children Hospitalized With Influenza. JAMA pediatrics, 171(3), 299-301. (Read full publication)
    174. Williams DJ, Edwards KM, Self WH, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Anderson EJ, Hicks LA, Bramley AM, Jain S, Grijalva C (2017). Effectiveness of ß-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia. JAMA pediatrics, 171(12), 1184-1191. (Read full publication)
    175. Pavia A (2017). Reducing diagnostic uncertainty to improve treatment of respiratory infections. The Lancet. Respiratory medicine, 5(5), 364-365. (Read full publication)
    176. Veesenmeyer AF, Olson JA, Hersh AL, Stockmann C, Korgenski K, Thorell EA, Pavia AT, Blaschke A (2016). A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures. Infectious diseases and therapy, 5(4), 555-570. (Read full publication)
    177. Hersh AL, Shapiro DJ, Pavia AT, Fleming-Dutra KE, Hicks L (2018). Geographic Variability in Diagnosis and Antibiotic Prescribing for Acute Respiratory Tract Infections. Infectious diseases and therapy, 7(1), 171-174. (Read full publication)
    178. Diaz MH, Benitez AJ, Cross KE, Hicks LA, Kutty P, Bramley AM, Chappell JD, Hymas W, Patel A, Qi C, Williams DJ, Arnold SR, Ampofo K, Self WH, Grijalva CG, Anderson EJ, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Jain S, Winchell J (2015). Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States. Open forum infectious diseases, 2(3), ofv106. (Read full publication)
    179. Grijalva CG, Wunderink RG, Zhu Y, Williams DJ, Balk R, Fakhran S, Courtney DM, Anderson EJ, Qi C, Trabue C, Pavia AT, Moore MR, Jain S, Edwards KM, Self W (2015). In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia. Open forum infectious diseases, 2(4), ofv135. (Read full publication)
    180. Diaz MH, Cross KE, Benitez AJ, Hicks LA, Kutty P, Bramley AM, Chappell JD, Hymas W, Patel A, Qi C, Williams DJ, Arnold SR, Ampofo K, Self WH, Grijalva CG, Anderson EJ, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Jain S, Winchell J (2016). Identification of Bacterial and Viral Codetections With Mycoplasma pneumoniae Using the TaqMan Array Card in Patients Hospitalized With Community-Acquired Pneumonia. Open forum infectious diseases, 3(2), ofw071. (Read full publication)
    181. Oboho IK, Bramley A, Finelli L, Fry A, Ampofo K, Arnold SR, Self WH, Williams DJ, Courtney DM, Zhu Y, Anderson EJ, Grijalva CG, McCullers JA, Wunderink RG, Pavia AT, Edwards KM, Jain (2016). Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia. Open forum infectious diseases, 4(1), ofw254. (Read full publication)
    182. Harris AM, Bramley AM, Jain S, Arnold SR, Ampofo K, Self WH, Williams DJ, Anderson EJ, Grijalva CG, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Winchell JM, Hicks L (2017). Influence of Antibiotics on the Detection of Bacteria by Culture-Based and Culture-Independent Diagnostic Tests in Patients Hospitalized With Community-Acquired Pneumonia. Open forum infectious diseases, 4(1), ofx014. (Read full publication)
    183. Bozio CH, Flanders WD, Finelli L, Bramley AM, Reed C, Gandhi NR, Vidal JE, Erdman D, Levine MZ, Lindstrom S, Ampofo K, Arnold SR, Self WH, Williams DJ, Grijalva CG, Anderson EJ, McCullers JA, Edwards KM, Pavia AT, Wunderink RG, Jain (2018). Use of Multiple Imputation to Estimate the Proportion of Respiratory Virus Detections Among Patients Hospitalized With Community-Acquired Pneumonia. Open forum infectious diseases, 5(4), ofy061. (Read full publication)
    184. Pillai SK, Beekmann SE, Babcock HM, Pavia AT, Koonin LM, Polgreen P (2015). Clinician Beliefs and Attitudes Regarding Use of Respiratory Protective Devices and Surgical Masks for Influenza. Health security, 13(4), 274-80. (Read full publication)
    185. Hick JL, Hanfling D, Wynia MK, Pavia A (2020). Duty to Plan: Health Care, Crisis Standards of Care, and Novel Coronavirus SARS-CoV-2. NAM perspectives, 2020, (Read full publication)
    186. Pavia A (1987). Diseases Associated with Raw Oysters. 3, 1.
    187. Christenson JC, Pavia AT, Woods ML, Carroll KC, Nichols (1996). Ochrabactrum anthropi meningitis from cadaveric pericardial dural gafts. 45, 671-673.
    188. Pavia A (1986). Cholera in Louisiana. 35, 687-8.
    189. Pavia AT, Cohen DM, Leber AL, Daly JA, Jackson JT, Selvarangan R, Kanwar N, Bender JM, Dien Bard J, Festekjian A, Duffy S, Larsen C, Holmberg KM, Bardsley T, Haaland B, Bourzac KM, Stockmann C, Chapin KC, Leung D (2023). Clinical Impact of Multiplex Molecular Diagnostic Testing in Children With Acute Gastroenteritis Presenting to an Emergency Department: A Multicenter Prospective Study. Clinical infectious diseases, (Read full publication)
    190. Arnold SR, Jain S, Dansie D, Kan H, Williams DJ, Ampofo K, Anderson EJ, Grijalva CG, Bramley AM, Pavia AT, Edwards KM, Nolan VG, McCullers JA, Kaufman R (2023). Association of Radiology Findings with Etiology of Community Acquired Pneumonia among Children. The Journal of pediatrics, 261, 113333. (Read full publication)
    191. Antoon JW, Nian H, Ampofo K, Zhu Y, Sartori LF, Johnson J, Arnold DH, Stassun J, Pavia AT, Grijalva CG, Williams D (2023). Validation of Childhood Pneumonia Prognostic Models for Use in Emergency Care Settings. Journal of the Pediatric Infectious Diseases Society, 12(8), 451-458. (Read full publication)
    192. Williams DJ, Martin JM, Nian H, Weitkamp AO, Slagle J, Turer RW, Suresh S, Johnson J, Stassun J, Just SL, Reale C, Beebe R, Arnold DH, Antoon JW, Rixe NS, Sartori LF, Freundlich RE, Ampofo K, Pavia AT, Smith JC, Weinger MB, Zhu Y, Grijalva C (2023). Antibiotic clinical decision support for pneumonia in the ED: A randomized trial. Journal of hospital medicine, 18(6), 491-501. (Read full publication)
    193. Freedman SB, Schnadower D, Estes M, Casper TC, Goldstein SL, Grisaru S, Pavia AT, Wilfond BS, Metheney M, Kimball K, Tarr PI, Hyperhydration to Improve Kidney Outcomes in children with Shiga Toxin-producing E. Coli infection (HIKO-STEC) Study Tea (2023). Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial). Trials, 24(1), 359. (Read full publication)
    194. Nelson EJ, Khan AI, Keita AM, Brintz BJ, Keita Y, Sanogo D, Islam MT, Khan ZH, Rashid MM, Nasrin D, Watt MH, Ahmed SM, Haaland B, Pavia AT, Levine AC, Chao DL, Kotloff KL, Qadri F, Sow SO, Leung D (2022). Improving Antibiotic Stewardship for Diarrheal Disease With Probability-Based Electronic Clinical Decision Support: A Randomized Crossover Trial. JAMA pediatrics, 176(10), 973-979. (Read full publication)
    195. Lee J, Zhu Y, Williams DJ, Self WH, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Anderson EJ, Jain S, Edwards KM, Grijalva C (2022). Red Blood Cell Distribution Width and Pediatric Community-Acquired Pneumonia Disease Severity. Hospital pediatrics, 12(9), 798-805. (Read full publication)
    196. Greene C, Nian H, Zhu Y, Antoon JW, Freundlich KL, Ampofo K, Sartori LF, Johnson J, Arnold DH, Gesteland P, Stassun J, Robison J, Pavia AT, Grijalva CG, Williams D (2022). Associations between comorbidity-related functional limitations and pneumonia outcomes. Journal of hospital medicine, 17(7), 527-533. (Read full publication)
    197. Sekmen M, Johnson J, Zhu Y, Sartori LF, Grijalva CG, Stassun J, Arnold DH, Ampofo K, Robison J, Gesteland PH, Pavia AT, Williams D (2022). Association Between Procalcitonin and Antibiotics in Children With Community-Acquired Pneumonia. Hospital pediatrics, 12(4), 384-391. (Read full publication)
    198. Kanwar N, Jackson J, Bardsley T, Pavia A, Bourzac KM, Holmberg K, Selvarangan (2023). Impact of Rapid Molecular Multiplex Gastrointestinal Pathogen Testing in Management of Children during a Shigella Outbreak. Journal of clinical microbiology, 61(3), e0165222. (Read full publication)
    199. Murray JL, Leung DT, Hanson OR, Ahmed SM, Pavia AT, Khan AI, Szymczak JE, Vaughn VM, Patel PK, Biswas D, Watt M (2024). Drivers of inappropriate use of antimicrobials in South Asia: A systematic review of qualitative literature. PLOS global public health, 4(4), e0002507. (Read full publication)
    200. Buckel WR, Hersh AL, Pavia AT, Jones PS, Owen-Smith AA, Stenehjem (2016). Antimicrobial Stewardship Knowledge, Attitudes, and Practices among Health Care Professionals at Small Community Hospitals. Hospital pharmacy, 51(2), 149-157. (Read full publication)
    201. Sartori LF, Nian H, Zhu Y, Johnson J, Stassun J, Ampofo K, Arnold DH, Antoon JW, Pavia AT, Grijalva CG, Williams D (2024). Removal of Race and White Blood Cell Count in an Updated Pediatric Pneumonia Severity Model. Hospital pediatrics, 14(3), e167-e169. (Read full publication)

    Review

    1. Pavia A (1994). Approach to food-borne and water-borne illness. Seminars in pediatric infectious diseases, 5, 222-230.
    2. Eccles R, Boivin G, Cowling BJ, Pavia A, Selvarangan (2023). Treatment of COVID-19 symptoms with over the counter (OTC) medicines used for treatment of common cold and flu. Clinical infection in practice, 19, 100230. (Read full publication)

    Book Chapter

    1. Pavia AT, Lowry PW, McFarland L, Bradford HB, Cook WL, Wachsmuth IK, Blake P (1987). Cholera in the United States 1986: The Widening Spectrum.
    2. Pavia AT, Siegler RL, Christofferson R, Milligan (1994). A 20-Year Population-Based Study of Hemolytic Uremic Syndrome: Evidence for the Importance of Shiga-Like Toxin Producting Escherichia coli. 25-28.
    3. Pavia A (2002). Salmonella, Shigella and enteric E. coli infections.
    4. Pavia A (2002). Evaluation of the returned traveller: Diarrhea and foodborne illness.
    5. Pavia A (2001). Food-Borne and Water Borne Disease.
    6. Pavia A (2003). Stavudine.
    7. Pavia A (2003). Infants and Children.
    8. Pavia A (1995). Food Poisoning.
    9. Pavia A (1996). Food-Borne and Water Borne Disease.
    10. Pavia A (1997). Food Poisoning.
    11. Pavia A (1999). Evaluation of the returned traveller: Diarrhea and foodborne illness.
    12. Pavia A (1999). Stavudine.
    13. Pavia AT, Christenson J (1999). Pediatric AIDS.
    14. Tauxe RV, Pavia A (1998). Salmonellosis: Nontyphoidal.
    15. Pavia A (1999). Food Poisoning.
    16. Fischer PR, Christenson JC, Pavia A (1999). Evaluation of the child returning from travel to a developing country.
    17. Pavia AT, Tauxe R (1991). Salmonellosis: Nontyphoidal.
    18. Pavia AT, Tauxe R (1991). Salmonellosis.
    19. Blaschke A, Pavia A (2009). Infectious Diarrhea.
    20. Pavia A (2009). Food Poisoning.
    21. Pavia A (2009). Salmonella, Shigella and enteric E. coli infections.
    22. Pavia A (2009). Food-Borne and Water Borne Disease.
    23. Pavia A (2009). Stavudine.
    24. Pavia A (2009). Managing HIV infection in children and adolescents.
    25. Pavia AT, Zar (2009). Pediatric HIV Infection.
    26. Doby E, Pavia A (2012). Managing HIV Infection in Children and Adolescents.

    Editorial

    1. Pavia A (2010). Mandate to protect patients from health care-associated influenza. Clinical infectious diseases, 50(4), 465-7. (Read full publication)
    2. Pavia A (2012). Editorial commentary: What did we learn from the emergency use authorization of peramivir in 2009?. Clinical infectious diseases, 55(1), 16-8. (Read full publication)
    3. Jain S, Pavia A (2016). Editorial Commentary: The Modern Quest for the "Holy Grail" of Pneumonia Etiology. Clinical infectious diseases, 62(7), 826-8. (Read full publication)
    4. Pavia A (2007). Germs on a plane: aircraft, international travel, and the global spread of disease. The Journal of infectious diseases, 195(5), 621-2. (Read full publication)
    5. Frank GM, Adalja A, Barbour A, Casadevall A, Dormitzer PR, Duchin J, Hayden FG, Hirsch MS, Hynes NA, Lipsitch M, Pavia AT, Relman D (2016). Infectious Diseases Society of America and Gain-of-Function Experiments With Pathogens Having Pandemic Potential. The Journal of infectious diseases, 213(9), 1359-61. (Read full publication)
    6. Pavia A (2016). Influenza Vaccine Effectiveness: Mysteries, Enigmas, and a Few Clues. The Journal of infectious diseases, 213(10), 1521-2. (Read full publication)
    7. Salmon DA, Pavia A, Gellin (2011). Editors' introduction: Vaccine safety throughout the product life cycle. Pediatrics, 127 Suppl 1, S1-4. (Read full publication)
    8. McGee ZA, Pavia A (1991). Is the concept, "agents of sexually transmitted disease" still valid?. Sexually transmitted diseases, 18(2), 69-71. (Read full publication)
    9. Bessesen MT, Savor-Price C, Simberkoff M, Reich NG, Pavia AT, Radonovich L (2013). N95 respirators or surgical masks to protect healthcare workers against respiratory infections: are we there yet?. American journal of respiratory and critical care medicine, 187(9), 904-5. (Read full publication)
    10. Pavia A (2004). Editorial comment: fixed-dose combination formulations are the answer, what was the question?. The AIDS reader, 14(10), 549. (Read full publication)
    11. Hersh AL, Pavia A (2015). Comparative Effectiveness Research in Pediatric Infectious Diseases. Journal of the Pediatric Infectious Diseases Society, 4(1), 28-9. (Read full publication)

    Letter

    1. Pavia AT, Riley DK (1993). Fluconazole prophylaxis in patients with leukemia. [Letter to the editor]. Ann Intern Med, 119(9), 951-2. (Read full publication)
    2. Stenehjem E, Hersh AL, Pavia A (2017). Reply to Buetti et al. Clinical infectious diseases, 64(7), 985-986. (Read full publication)
    3. Uyeki TM, Ison MG, Wolfe CR, Pavia A (2020). Reply to Verweij et al. Clinical infectious diseases, 70(2), 350-351. (Read full publication)
    4. Pavia AT, Ison MG, Wolfe CR, Uyeki T (2020). Response to Apewokin and Onyishi. Clinical infectious diseases, 70(12), 2749-2750. (Read full publication)
    5. Pavia AT, Campbell JF, Blake PA, Smith JD, McKinley TW, Martin D (1987). Cholera from raw oysters shipped interstate. JAMA, 258(17), 2374. (Read full publication)
    6. Bonkowsky J, Pavia (2007). Cerebral vasculopathy with aneurysm formation in HIV-infected young adults. Neurology, 68(8), 623; author reply 623. (Read full publication)
    7. Blaschke AJ, Byington CL, Ampofo K, Pavia AT, Heyrend C, Rankin SC, McGowan KL, Harris MC, Shah S (2013). Species-specific PCR improves detection of bacterial pathogens in parapneumonic empyema compared with 16S PCR and culture. The Pediatric infectious disease journal, 32(3), 302-3. (Read full publication)
    8. Stockmann C, Ampofo K, Hersh AL, Bennett TD, Boulton R, Plant P, Byington CL, Pavia A (2013). Local Health Department Influenza Surveillance Estimates and Projections of Peak Pediatric Intensive Care Unit Occupancy During the 2009 Influenza A Pandemic. Journal of the Pediatric Infectious Diseases Society, 2(4), 405-6. (Read full publication)
    9. Stockmann C, Sherwin CM, Knackstedt ED, Hersh AL, Pavia AT, Spigarelli M (2016). Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children. Journal of the Pediatric Infectious Diseases Society, 5(2), 231-232. (Read full publication)
    10. Pavia A (1986). Salmonellosis in a School System. 36, 74-75.

    Newspaper

    1. Pavia A (2016). Op-ed: Hatch bill is PATH forward to developing new antibiotics.

    Other

    1. Kim L, Rha B, Abramson JS, Anderson LJ, Byington CL, Chen GL, DeVincenzo J, Edwards KM, Englund JA, Falsey AR, Griffin MR, Karron RA, Martin KG, Meissner HC, Munoz FM, Pavia AT, Piedra PA, Schaffner W, Simões EAF, Singleton R, Talbot HK, Walsh EE, Zucker JR, Gerber S (2017). Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines. Clinical infectious diseases, 65(6), 1020-1025. (Read full publication)
    2. Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT, Rubinstein E, Holty JE, Messonnier NE, Smith TL, Pesik N, Treadwell TA, Bower WA, Workgroup on Anthrax Clinical Guidelines (2014). Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerging infectious diseases, 20(2), (Read full publication)
    3. Pavia A (1989). Legionella: Review of a Continuing Nosocomial Problem.
    4. Samore MH, Looney A, Orleans B, Greene T, Seegert N, Delgado JC, Presson A, Zhang C, Ying J, Zhang Y, Shen J, Slev P, Gaulin M, Yang MJ, Pavia AT, Alder S (2021). Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA. Emerging infectious diseases, 27(11), 2786-2794. (Read full publication)
    5. Duong KNC, Le LM, Veettil SK, Saidoung P, Wannaadisai W, Nelson RE, Friedrichs M, Jones BE, Pavia AT, Jones MM, Samore MH, Chaiyakunapruk (2023). Disparities in COVID-19 related outcomes in the United States by race and ethnicity pre-vaccination era: an umbrella review of meta-analyses. Frontiers in public health, 11, 1206988. (Read full publication)
    6. Turer RW, Gradwohl S, Stassun J, Johnson J, Slagle J, Reale C, Beebe R, Nian H, Zhu Y, Albert D, Coffman T, Alaw H, Wilson T, Just S, Peguillan P, Freeman H, Arnold DH, Martin JM, Suresh S, Coglio S, Hixon R, Ampofo K, Pavia AT, Weinger M, Williams D, Ozdas Weitkamp (2024). User-Centered Design and Implementation of an Interoperable FHIR Application for Pediatric Pneumonia Prognostication in a Randomized Trial. Applied clinical informatics, (Read full publication)

  • News & Podcasts

    News